Doctor profile · Federal record
Dr. MONICA CEPEDA, APRN FNP-C
Family Nurse Practitioner (CMS: NURSE PRACTITIONER) · EL PASO, TX
- NPI 1053061804
- Accepts Medicare
- 5 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
11989 PELLICANO DR
EL PASO, TX 799366287
(915) 857-0700 - Additional location
-
1521 Joe Battle Blvd
El Paso, TX 799360922
(915) 790-5700 - Additional location
-
4824 Alberta Ave Fl 4
El Paso, TX 799052709
(915) 521-7731 - Mailing address
-
3849 TIERRA CAMPA DR
EL PASO, TX 799384372
Credentials & registration
- NPI registered
- March 2022 — 4 yrs on file
- Profile last updated
- March 28, 2025
- Year of graduation
- 2021 — 5 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Texas #1073645
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1053061804. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
66
Distinct HCPCS
1
Medicare allowed
$4,091
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 66 | 25 | $62 |
In context: peer comparison
Among 78 peers in this city , average services per provider: 99. This provider delivers 0.7× the peer median.Open Payments
Industry payments received
All-time total
$822
Transactions
30
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $227.87 | |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $142.47 | |
| Otsuka America Pharmaceutical, Inc. | 4 | $80.87 | |
| Ardelyx, Inc. | 3 | $68.11 | |
| OPKO Pharmaceuticals, LLC | 3 | $59.03 | |
| Merck Sharp & Dohme LLC | 2 | $51.21 | |
| Amgen Inc. | 2 | $46.33 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39.34 | |
| Melinta Therapeutics, LLC | 1 | $29.96 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22.82 | |
| Travere Therapeutics, Inc. | 2 | $18.70 | |
| CorMedix Inc. | 1 | $18.57 | |
| Novo Nordisk Inc | 1 | $16.39 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
709
Patients
261
Total drug cost
$282,066
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Calcitriol | Generic | 198 | 74 | $1,734 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 122 | 43 | $124,017 |
| Amlodipine Besylate | Generic | 66 | 27 | $379 |
| Veltassa (Patiromer Calcium Sorbitex) | Brand | 51 | 19 | $51,497 |
| Kerendia (Finerenone) | Brand | 41 | 20 | $48,439 |
| Lisinopril | Generic | 38 | 17 | $186 |
| Losartan Potassium | Generic | 36 | 18 | $555 |
| Lokelma (Sodium Zirconium Cyclosilicate) | Brand | 25 | 0 | $20,498 |
| Cefuroxime (Cefuroxime Axetil) | Brand | 24 | 20 | $214 |
| Torsemide | Generic | 23 | 12 | $285 |